Skip to main content
. 2023 Jun 6;14:90. doi: 10.1007/s12672-023-00678-3

Table 1.

Patient characteristics of ITT and PP population

ITT population PP population
Control group
(n = 43)
Experimental group
(n = 38)
p-value Control group
(n = 36)
Experimental group
(n = 32)
p-value
Patient demographic Patient demographic
Age (years) Age (years)
Mean ± sd 55.5 ± 11.8 55.9 ± 10.6 0.992 Mean ± sd 55.3 ± 12.6 55.1 ± 10.9 0.64
Median (IQR) 57.0 (48.0–64.0) 56.5 (50.0–63.0) Median (IQR) 57.5 (46.0-64.5) 55.5 (49.5–61.0)
 <65 33 (76.7) 32 (84.2) 0.4  <65 27 (75.0) 28 (87.5) 0.191
 ≥65 10 (23.3) 6 (15.8)  ≥65 9 (25.0) 4 (12.5)
sex sex
 Male 21 (48.8) 22 (57.9) 0.415  Male 17 (47.2) 20 (62.5) 0.207
 Female 22 (51.2) 16 (42.1)  Female 19 (52.8) 12 (37.5)
Physical examination Physical mxamination
 Height (cm)  Height (cm)
 Mean ± sd 164.7 ± 9.6 164.6 ± 11.2 0.773  mean ± sd 164.5 ± 9.2 165.0 ± 11.8 0.522
 Median (IQR) 163.0 (157.0-173.0) 166.5 (156.0-173.0)  median (IQR) 163.0 (157.0-172.5) 170.0 (157.5–174.0)
 Weight (kg)  Weight (kg)
 Mean ± sd 62.6 ± 12.4 68.0 ± 12.9 0.052  mean ± sd 62.4 ± 11.7 69.2 ± 13.4 0.038
 Median (IQR) 62.0(52.0–73.0) 66.0(59.0–81.0)  median (IQR) 63.0(52.0–73.0) 69.5(59.5–81.0)
Karnofsky Performance Status (KPS) Karnofsky performance status (KPS)
 60 9 (20.9) 4 (10.5) 0.103  60 8 (22.2) 2 (6.3) 0.18
 70 4 (9.3) 11 (28.9)  70 4 (11.1) 9 (28.1)
 80 14 (32.6) 9 (23.7)  80 12 (33.3) 9 (28.1)
 90 12 (27.9) 13 (34.2)  90 10 (27.8) 11 (34.4)
 100 4 (9.3) 1 (2.6)  100 2 (5.6) 1 (3.1)
MGMT methylation MGMT methylation
 No 24 (57.1) 29 (78.4) 0.045  No 19 (54.3) 24 (77.4) 0.049
 Yes 18 (42.9) 8 (21.6)  Yes 16 (45.7) 7 (22.6)

ITT intention-to-treat; PP per-protocol population; sd standard deviation; IQR interquartile range; cm centimeters; kg kilograms; MGMT O6-methylguanine-DNA methyltransferase